Join this group to share and discuss HIV cases with a global network of peers.

Explore the importance of early diagnosis and detecting opportunistic infections, and discuss the impact of promptly initiating triple therapy on improved patient outcomes and quality of life.

This group is a part of an independent education program, funded by Gilead. Gilead did not influence the content and their employees do not have access to the MedShr platform. Please email info@medshr.net if you would like further information.


HIV Education Group

HIV drug resistance, clinical implications and strategies to prevent and manage resistance. 

MedShr Editor

This module aims to inform healthcare practitioners on the mechanisms of HIV drug resistance, factors which contribute to drug resistances and the clinical consequences. This learning module is part of an independent medical education programme funded by Gilead. Gilead employees do not have access to the MedShr platform

HIV Drug Resistance - Part 1 

The second part of this learning series will focus on strategies for preventing the development of HIV drug resistance including disease prevention, rapid diagnosis, population monitoring and resistance testing. 

HIV Drug Resistance - Part 2 

This learning series has been created to inform health care practitioners about HIV drug resistance, the clinical implications and strategies to prevent and manage resistance. This Learning series has been sponsored by Gilead. Gilead employees do not have access to the MedShr Platform.

HIV and drug resistance